Device tax seen as invisible in healthcare repeal efforts————————————-

Device tax seen as invisible in healthcare repeal efforts————————————-

Seconding that viewpoint, albeit with some reservations, was Dean Rosen, a partner with the lobbying firm of Mehlman Vogel Castagnetti (MVC; Washington), who commented that the device tax issue “points out two interesting broader questions.” One of these, he said is the question of how any changes to PPACA are presented. “How are they positioned?” in the public’s view, he asked. ┬áHe noted that Congress will not succeed in selling any changes to the public unless “a number of those industry fees…can be portrayed as things that are going to increase the cost of underlying products and hence boost healthcare insurance premiums or cost-sharing.”

Device tax seen as invisible in healthcare repeal efforts————————————-